Jared Schwartz, MD, Ph.D.
Jared N. Schwartz, MD, Ph.D., Senior NMG Consultant, is board certified in anatomic and clinical pathology with subspecialty boards in medical microbiology and cytopathology. He is a distinguished medical professional, patient advocate and pathology leader who has paved the way for groundbreaking strategies that improve patient outcomes. He is listed in “Top Doctors in America” and has been recognized by the College of American Pathology as “Pathologist of the Year”. As a key influencer in the pathology community, he interacts regularly with key opinion leaders (KOLs), medical and advocacy societies, and medical directors of major clinical and regulatory organizations.
Sought after as an industry “Expert” by the media, Dr. Schwartz has given over a thousand lectures and media interviews on a variety of medical topics and has served on consensus groups for the Centers for Disease Control (CDC) on setting national laboratory testing standards. He has represented the College of American Pathologists (CAP), testifying before Congress and at the White House on laboratory quality issues. He was appointed as Chairman of the College of American Pathologists Committee on National Laboratory Preparedness following “9-11,” establishing worldwide laboratory protocols in only 24 hours. He testified before Congress in May 2003 on SARS, and was interviewed live on CNN during during the Monkey Pox outbreak. He has been on Good Morning America and CNN providing information on influenza and has given over 250 international media interviews.
Prior to his consulting career, Dr. Schwartz served as Director of Pathology for Novant Health in Charlotte, NC. He also served as Chief Medical Officer of Aperio. Dr. Schwartz was instrumental in strategic business matters and emerging medical technology solutions that impact patient care.
Dr. Schwartz currently serves on the Board of Directors of the Personalized Medicine Coalition (PMC), the American Pathology Foundation, and the Program Planning Committee of the Annual Harvard Symposium on Personalized Medicine. He previously served as Consulting Professor at Stanford University, School of Medicine, and a member of the Stanford Medical Center, Personalized Medicine and Genomics Committee. He has held numerous lead positions in state and national medical associations and served on Board of Governors of the College of American Pathologists (CAP), and was the nationally elected President of CAP from 2007-2009.
Dr. Schwartz is a graduate of Duke University Medical School where he obtained an M.D. (1973) and Ph.D. (1975) and completed his residency and fellowship training serving as the 1st Chief Resident in Pathology in 1977.
Dr. Schwartz resides in North Carolina with his family.